681 related articles for article (PubMed ID: 19854938)
1. Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents.
Stein CA; Hansen JB; Lai J; Wu S; Voskresenskiy A; Høg A; Worm J; Hedtjärn M; Souleimanian N; Miller P; Soifer HS; Castanotto D; Benimetskaya L; Ørum H; Koch T
Nucleic Acids Res; 2010 Jan; 38(1):e3. PubMed ID: 19854938
[TBL] [Abstract][Full Text] [Related]
2. Silencing of gene expression by gymnotic delivery of antisense oligonucleotides.
Soifer HS; Koch T; Lai J; Hansen B; Hoeg A; Oerum H; Stein CA
Methods Mol Biol; 2012; 815():333-46. PubMed ID: 22131003
[TBL] [Abstract][Full Text] [Related]
3. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.
Torres AG; Threlfall RN; Gait MJ
Artif DNA PNA XNA; 2011; 2(3):71-8. PubMed ID: 22567190
[TBL] [Abstract][Full Text] [Related]
4. Protein Kinase C-α is a Critical Protein for Antisense Oligonucleotide-mediated Silencing in Mammalian Cells.
Castanotto D; Lin M; Kowolik C; Koch T; Hansen BR; Oerum H; Stein CA
Mol Ther; 2016 Jun; 24(6):1117-1125. PubMed ID: 26961407
[TBL] [Abstract][Full Text] [Related]
5. Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection.
Zhang Y; Qu Z; Kim S; Shi V; Liao B; Kraft P; Bandaru R; Wu Y; Greenberger LM; Horak ID
Gene Ther; 2011 Apr; 18(4):326-33. PubMed ID: 21179173
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Distribution and Nuclear Activity of Antisense Oligonucleotides After Unassisted Uptake in Myoblasts and Differentiated Myotubes In Vitro.
González-Barriga A; Nillessen B; Kranzen J; van Kessel IDG; Croes HJE; Aguilera B; de Visser PC; Datson NA; Mulders SAM; van Deutekom JCT; Wieringa B; Wansink DG
Nucleic Acid Ther; 2017 Jun; 27(3):144-158. PubMed ID: 28375678
[TBL] [Abstract][Full Text] [Related]
7. Quantitative fluorescence imaging determines the absolute number of locked nucleic acid oligonucleotides needed for suppression of target gene expression.
Buntz A; Killian T; Schmid D; Seul H; Brinkmann U; Ravn J; Lindholm M; Knoetgen H; Haucke V; Mundigl O
Nucleic Acids Res; 2019 Jan; 47(2):953-969. PubMed ID: 30462278
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
Sypniewski D; Bednarek I; Gałka S; Loch T; Błaszczyk D; Sołtysik D
Acta Pol Pharm; 2013; 70(1):87-97. PubMed ID: 23610963
[TBL] [Abstract][Full Text] [Related]
9. Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense.
Moschos SA; Frick M; Taylor B; Turnpenny P; Graves H; Spink KG; Brady K; Lamb D; Collins D; Rockel TD; Weber M; Lazari O; Perez-Tosar L; Fancy SA; Lapthorn C; Green MX; Evans S; Selby M; Jones G; Jones L; Kearney S; Mechiche H; Gikunju D; Subramanian R; Uhlmann E; Jurk M; Vollmer J; Ciaramella G; Yeadon M
Mol Ther; 2011 Dec; 19(12):2163-8. PubMed ID: 21971426
[TBL] [Abstract][Full Text] [Related]
10. Chemical modification study of antisense gapmers.
Stanton R; Sciabola S; Salatto C; Weng Y; Moshinsky D; Little J; Walters E; Kreeger J; DiMattia D; Chen T; Clark T; Liu M; Qian J; Roy M; Dullea R
Nucleic Acid Ther; 2012 Oct; 22(5):344-59. PubMed ID: 22852836
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Silencing of lncRNAs Using LNA GapmeRs.
Taiana E; Favasuli V; Ronchetti D; Morelli E; Tassone P; Viglietto G; Munshi NC; Neri A; Amodio N
Methods Mol Biol; 2021; 2348():157-166. PubMed ID: 34160805
[TBL] [Abstract][Full Text] [Related]
12. LNA-antisense rivals siRNA for gene silencing.
Jepsen JS; Wengel J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
[TBL] [Abstract][Full Text] [Related]
13. Antisense Oligonucleotide in LNA-Gapmer Design Targeting TGFBR2-A Key Single Gene Target for Safe and Effective Inhibition of TGFβ Signaling.
Kuespert S; Heydn R; Peters S; Wirkert E; Meyer AL; Siebörger M; Johannesen S; Aigner L; Bogdahn U; Bruun TH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32178467
[TBL] [Abstract][Full Text] [Related]
14. Antisense 2'-Deoxy, 2'-Fluroarabino Nucleic Acids (2'F-ANAs) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids.
Souleimanian N; Deleavey GF; Soifer H; Wang S; Tiemann K; Damha MJ; Stein CA
Mol Ther Nucleic Acids; 2012 Sep; 1(10):e43. PubMed ID: 23344235
[TBL] [Abstract][Full Text] [Related]
15. A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells.
Castanotto D; Lin M; Kowolik C; Wang L; Ren XQ; Soifer HS; Koch T; Hansen BR; Oerum H; Armstrong B; Wang Z; Bauer P; Rossi J; Stein CA
Nucleic Acids Res; 2015 Oct; 43(19):9350-61. PubMed ID: 26433227
[TBL] [Abstract][Full Text] [Related]
16. A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo.
Gupta N; Fisker N; Asselin MC; Lindholm M; Rosenbohm C; Ørum H; Elmén J; Seidah NG; Straarup EM
PLoS One; 2010 May; 5(5):e10682. PubMed ID: 20498851
[TBL] [Abstract][Full Text] [Related]
17. The intratracheal administration of locked nucleic acid containing antisense oligonucleotides induced gene silencing and an immune-stimulatory effect in the murine lung.
Uemura Y; Hagiwara K; Kobayashi K
PLoS One; 2017; 12(11):e0187286. PubMed ID: 29107995
[TBL] [Abstract][Full Text] [Related]
18. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides.
Grossen P; Portmann M; Koller E; Duschmalé M; Minz T; Sewing S; Pandya NJ; van Geijtenbeek SK; Ducret A; Kusznir EA; Huber S; Berrera M; Lauer ME; Ringler P; Nordbo B; Jensen ML; Sladojevich F; Jagasia R; Alex R; Gamboni R; Keller M
Eur J Pharm Biopharm; 2021 Jan; 158():198-210. PubMed ID: 33248268
[TBL] [Abstract][Full Text] [Related]
20. Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis.
Buck AC; Shen C; Schirrmeister H; Schmid-Kotsas A; Munzert G; Guhlmann A; Mehrke G; Klug N; Gross HJ; Bachem M; Reske SN
Cancer Biother Radiopharm; 2002 Jun; 17(3):281-9. PubMed ID: 12136520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
